ProQR Therapeutics N.V.

NASDAQ: PRQR · Real-Time Price · USD
2.04
0.02 (0.99%)
At close: Aug 15, 2025, 3:59 PM
2.05
0.24%
After-hours: Aug 15, 2025, 04:10 PM EDT

ProQR Therapeutics Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4.52M 4.31M 3.84M 6.34M 4.48M 3.2M 1.37M 1.21M 655K 822K 956K 1.02M 1.23M 239K 872K 243K n/a
Cost of Revenue
n/a n/a n/a 714.6K 695.07K n/a n/a n/a n/a 712.92K n/a n/a n/a n/a n/a n/a 646.67K
Gross Profit
4.52M 4.31M 3.84M 5.62M 3.78M 3.2M 1.37M 1.21M 655K 109.08K 956K 1.02M 1.23M 239K 872K 243K -646.67K
Operating Income
-10.82M -10.08M -8.72M -3.77M -8.33M -8.96M -7.39M -8.81M -9.39M -12.36M -19.68M -15.74M -16.94M -17.33M -14.56M -13.2M -12.1M
Interest Income
n/a n/a n/a 515.59K 490.87K 824.29K 373.56K 468.97K n/a 575.67K n/a n/a n/a -890K n/a n/a n/a
Pretax Income
-10.08M -9.3M -8.11M -2.89M -7.7M -5.34M -5.46M -8.02M -8.86M -11.39M -24.31M -14.65M -14.44M -18.22M -15.03M -15.7M -12.61M
Net Income
-10.08M -9.3M -8.11M -2.69M -7.7M -5.34M -5.71M -7.99M -7.99M -10.63M -24.38M -14.67M -14.45M -18.22M -15.05M -15.75M -12.61M
Selling & General & Admin
3.23M 3.91M 3.28M 3.01M 2.78M 3.92M 3.31M 4.14M 4.03M 2.97M 5.36M 5.41M 4.91M 5.32M 4.59M 4.12M 3.34M
Research & Development
12.32M 10.61M 9.41M 7.05M 9.34M 7.53M 5.45M 5.91M 6.06M 10.7M 15.35M 11.45M 13.37M 12.46M 11.12M 9.73M 8.9M
Other Expenses
-222K -136K -138K -156K -68K -56K n/a n/a -42K -765K 79K 161K -101K n/a n/a n/a -729K
Operating Expenses
15.34M 14.39M 12.56M 9.9M 12.11M 11.45M 8.76M 10.05M 10.04M 12.91M 20.71M 16.86M 18.17M 17.77M 15.71M 13.86M 12.1M
Interest Expense
n/a n/a n/a 2.59K 2.87K -276.71K 10.56K -1.03K n/a 739K n/a n/a n/a 19K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -674.75K -831.2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
15.34M 14.39M 12.56M 10.06M 12.81M 12.16M 8.76M 10.05M 10.04M 12.91M 20.71M 16.86M 18.17M 17.77M 15.71M 13.86M 12.1M
Income Tax Expense
n/a n/a n/a -200K 3.02K 4.87K -41K -42K -864K -758K 69K 20K 7K 22K 35K 53K 7K
Shares Outstanding (Basic)
105.3M 81.67M 81.67M 81.67M 81.57M 78.46M 81M 80.94M 80.89M 77.39M 71.38M 71.36M 71.36M 71.24M 68.26M 66.15M 50.81M
Shares Outstanding (Diluted)
105.3M 81.67M 81.67M 81.67M 81.57M 78.46M 81M 80.94M 80.89M 77.39M 71.38M 71.36M 71.36M 71.24M 68.26M 66.15M 50.81M
EPS (Basic)
-0.1 -0.11 -0.1 -0.03 -0.09 -0.07 -0.07 -0.1 -0.1 -0.14 -0.34 -0.21 -0.2 -0.26 -0.22 -0.24 -0.25
EPS (Diluted)
-0.1 -0.11 -0.1 -0.03 -0.09 -0.07 -0.07 -0.1 -0.1 -0.14 -0.34 -0.21 -0.2 -0.26 -0.22 -0.24 -0.25
EBITDA
-10.14M -5.82M -8.17M -3.04M -7.38M -8.25M -6.75M -8.26M -8.84M -6.29M -19.29M -15.34M -16.47M -17.74M -14.3M -13.01M -11.47M
EBIT
-10.82M -6.49M -8.85M -3.76M -8.07M -1.02M -7.39M -8.85M -9.39M -7.04M -19.9M -15.93M -17.04M -18.3M -14.84M -13.61M -12.1M
Depreciation & Amortization
678K 671K 688K 711K 695.07K 709.32K 660.67K 592.69K 543.5K 712.92K 628.67K 600.17K 577.87K 555.1K 553.75K 612.01K 646.67K